Update and report coming out Monday being the 27th Feb. Get yourself set. I would not expect any further change to the downside on numbers than what was reported on Feb 7th.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%